Start: 11 Nov 2021, 14:15
End: 11 Nov 2021, 15:15
Chair: Dr Eileen Parkes, University of Oxford, UK
This session is jointly organised with the British Society for Immunology.
Abstract title: Efficacy of avelumab + axitinib (A + Ax) vs sunitinib (S) by IMDC risk group in advanced renal cell carcinoma (aRCC): extended follow-up results from JAVELIN Renal 101
Abstract title: Comprehensive evaluation of risk factors associated with immune checkpoint blockade-induced hepatitis
Abstract title: Harnessing liver-resident gamma delta T cells for immunotherapy of hepatocellular carcinoma